LONDON, Oct 24 (Reuters) - Britain's medicines regulator
said on Friday it had made the world's largest seizure of
unlicensed weight-loss medicines, dismantling a factory that
made jabs labelled as containing the ingredient in Eli Lilly's ( LLY )
Mounjaro.
Global pharmaceutical companies and regulators have
raised alarms over a surge in counterfeit and unregulated
weight-loss drugs, which are being trafficked globally and sold
illegally online and through underground networks.
The Medicines and Healthcare products Regulatory Agency
(MHRA) said it had seized 2,000 injection pens labelled as
containing tirzepatide - the ingredient in Eli Lilly's ( LLY )
Mounjaro and Zepbound - and retatrutide, an experimental obesity
drug also made by Eli Lilly ( LLY ), which is still in trials.
Tens of thousands of empty pens were also seized, along with
raw chemicals.
Eli Lilly ( LLY ) did not immediately respond to a request for
comment.
FIRST FACTORY DISCOVERY IN UK
The agency said the factory in central England was the first
of its kind discovered in Britain.
"This is a victory in the fight against the shameless
criminals who are putting lives at risk by peddling dangerous
and illegal weight loss jabs to make a quick buck," health
minister Wes Streeting said in a statement.
"These unregulated products, made with no regard for safety
or quality, posed a major risk to unwitting customers."
Both tirzepatide and retatrutide mimic hormones that
suppress appetite and regulate blood sugar.
Britain's National Health Service prescribes weight-loss
medicines only to patients who meet certain criteria. For those
who obtain them privately, the drugs can cost hundreds of pounds
per month.
In the United States, some people
have begun sourcing
raw ingredients online to self-manufacture GLP-1-based
injections such as semaglutide - a drug developed by Novo
Nordisk and used in Ozempic and Wegovy - citing high
retail prices and limited access.
The trend has raised safety concerns among health
officials, who warn that DIY formulations pose serious health
risks due to contamination, incorrect dosing and lack of
oversight.
($1 = 0.7451 pounds)